Scabigard Suspension Class II Recall - Product Defect Affecting Efficacy
Summary
The UK Veterinary Medicines Directorate (VMD) has issued a Class II recall alert for Scabigard Suspension for Cutaneous Administration (Vm 42058/5173 and Vm 60021/3020) manufactured by Zoetis. The affected batches may fail to demonstrate expected signs of 'take' following administration. Nine batch numbers are affected, manufactured between June 2024 and January 2025, with expiry dates through December 2026. Wholesalers and veterinarians are required to immediately review inventory and quarantine affected products.
What changed
The VMD has announced a Class II recall for Scabigard Suspension for Cutaneous Administration, a veterinary pharmaceutical product. The recall applies to nine specific batch numbers manufactured by Zoetis between June 2024 and January 2025. The product defect means affected batches may not demonstrate the expected therapeutic response ('take') following administration.
Wholesalers and veterinarians must immediately review their inventory, identify affected batches, and quarantine the product. End users who have purchased the product should return it to the veterinary practice from which it was obtained. Zoetis is directly contacting the supply chain to facilitate returns and replacements.
What to do next
- Quarantine affected product batches immediately
- Contact Zoetis at 0345 300 8034 for return instructions
- Return affected product to veterinary practice
Archived snapshot
Apr 15, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
News story
Scabigard Suspension for Cutaneous Administration - product defect recall alert
Product defect recall alert for Scabigard Suspension for Cutaneous Administration - Vm 42058/5173 and Vm 60021/3020 by Zoetis Belgium S.A.
From: Veterinary Medicines Directorate Published 2 April 2026
We wish to inform wholesalers, veterinarians and end users that Zoetis has initiated a Class II recall for Scabigard Suspension for Cutaneous Administration, UK(GB) Vm 42058/5173 by Zoetis UK Limited and UK(NI) Vm 60021/3020 by Zoetis Belgium S.A.
The reason for this recall is that the affected batches may not demonstrate the expected signs of take following administration.
This recall applies to the following batches:
| Batch number | Date of manufacture | Expiry date |
|---|---|---|
| 7482095A01 | June 2024 | May 2026 |
| 7482095A02 | June 2024 | May 2026 |
| 7482095B01 | June 2024 | May 2026 |
| 7482095B02 | June 2024 | May 2026 |
| 7482095D01 | June 2024 | May 2026 |
| 7482095D02 | June 2024 | May 2026 |
| 7482096A01 | August 2024 | July 2026 |
| 748209701 | January 2025 | December 2026 |
| 748209702 | January 2025 | December 2026 |
Zoetis is contacting wholesalers and veterinarians to immediately review inventory and quarantine products subject to this recall.
End users should return any affected product to the veterinary practice from which it was purchased.
For further information regarding this recall, please contact Zoetis on 0345 300 8034 or at customersupportUK@zoetis.com.
Share this page
The following links open in a new tab
Updates to this page
Published 2 April 2026
Related changes
Get daily alerts for UK VMD
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from VMD.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when UK VMD publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.